par Lauritsen, K;Devière, Jacques 
;Bigard, M-A;Bayerdörffer, E;Mózsik, G;Murray, F;Kristjánsdóttir, S;Savarino, V;Vetvik, K;De Freitas, D;Orive, V;Rodrigo, L;Fried, M;Morris, J;Schneider, H;Eklund, S;Larkö, A
Référence Alimentary pharmacology & therapeutics, 17 Suppl 1, page (333-341)
Publication Publié, 2003-02
;Bigard, M-A;Bayerdörffer, E;Mózsik, G;Murray, F;Kristjánsdóttir, S;Savarino, V;Vetvik, K;De Freitas, D;Orive, V;Rodrigo, L;Fried, M;Morris, J;Schneider, H;Eklund, S;Larkö, ARéférence Alimentary pharmacology & therapeutics, 17 Suppl 1, page (333-341)
Publication Publié, 2003-02
Article révisé par les pairs
| Titre: |
|
| Auteur: | Lauritsen, K; Devière, Jacques; Bigard, M-A; Bayerdörffer, E; Mózsik, G; Murray, F; Kristjánsdóttir, S; Savarino, V; Vetvik, K; De Freitas, D; Orive, V; Rodrigo, L; Fried, M; Morris, J; Schneider, H; Eklund, S; Larkö, A |
| Informations sur la publication: | Alimentary pharmacology & therapeutics, 17 Suppl 1, page (333-341) |
| Statut de publication: | Publié, 2003-02 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | 2-Pyridinylmethylsulfinylbenzimidazoles |
| Anti-Ulcer Agents -- administration & dosage | |
| Dose-Response Relationship, Drug | |
| Double-Blind Method | |
| Esophagitis, Peptic | |
| Humans | |
| Omeprazole -- administration & dosage | |
| Omeprazole -- analogs & derivatives | |
| Note générale: | Clinical Trial |
| Journal Article | |
| Multicenter Study | |
| Randomized Controlled Trial | |
| Research Support, Non-U.S. Gov't | |
| FLWIN | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0269-2813 |
| info:doi/10.1046/j.1365-2036.2003.01464.x | |
| info:pii/200 | |
| info:scp/0037325724 | |
| info:pmid/12614304 |
